Sytrinol License Returns to KGK Synergize

In accordance with the terms of a binding agreement, the global distribution rights to Sytrinol, a supplement that supports healthy cholesterol, will return to its inventor and patent holder, KGK Synergize Inc., London, Ontario, Canada, as of January 1, 2009. Until that time Sytrinol will be available through its current distribution licensee, SourceOne Global Partners, Chicago, IL.